At the end of November 2022, the Swiss Parliament voted in favor of FDA (US Food & Drug Administration) approval of US medical devices. On Monday, November 28, a motion for “more leeway in the procurement of medical devices to supply the Swiss population” was passed in the Swiss Parliament.
Swiss Medtech described this as a “necessary and urgent decision” and stated that it was “essential” that this mandate now be implemented swiftly and pragmatically. In other countries, such as Australia and Israel, this parallel procedure of FDA approvals for CE marking has proven successful!
It can also be done more efficiently; Switzerland is leading the way in Europe!
